Adding risk factors for potentially resistant pathogens, increasing antibiotic pressure and risk creating the "untreatable bacteria": Time to change direction

Intensive Care Medicine

Volumn 39, Issue 4, 2013, Pages 779-781

  Paiva, José Artur ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM DERIVATIVE; CEFTAZIDIME; NUCLEOSIDE DIPHOSPHATE KINASE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HOSPITAL ACQUIRED PNEUMONIA; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KLEBSIELLA PNEUMONIAE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NURSING HOME; PATHOGENESIS; PRACTICE GUIDELINE; PSEUDOMONAS AERUGINOSA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEPSIS; SEPTIC SHOCK; TREATMENT DURATION; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INTENSIVE CARE UNITS; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; TIME FACTORS;

EID: 84875472001     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-012-2811-x     Document Type: Review

References (12)

1. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, Gibert C (1998) Ventilator-associated pneumonia caused by potentially drug resistant bacteria. Am J Respir Crit Care Med 157:531-539
2. ATS/IDSA (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated and health care associated pneumonia. Am J Respir Crit Care Med 171:388-416
3. Martin-Loeches I, Deja M, Koulenti D, Dimopoulos G, Marsh B, Torres A, Niederman M, Rello J (2013) Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk. Intensive Care Med. doi: 10.1007/s00134-012-2808-5
4. Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH (2008) Predictors of 30-day mortality and hospital costs in patient with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest 134:1208-1216
5. Koo SH, Kwon KC, Cho HH, Sung JY (2010) Genetic basis of multi-resistant Acinetobacter baumannii clinical isolates from three university hospitals in Chungcheong Province, Korea. Korean J Lab Med 30:498-506
6. Kumarasamy KK, Toleman MA, Walsh TR et al (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan and the UK: a molecular, biological and epidemiological study. Lancet Infect Dis 10:597-602
7. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, Jarlier V, Levy SB, N′Doye B, Pittet D, Richtmann R, Seta WH, van der Meer JWM, Voss A (2011) Society's failure to protect a precious resource: antibiotics. Lancet 378:369-371
8. Damas P, Layios N, Seidel L, Nys M, Melin P, Ledoux D (2011) Severity of ICU-acquired pneumonia according to infectious microorganisms. Intensive Care Med 37:1128-1135
9. Dellit T, Owens R, McGowan J et al (2007) Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 44:159-177
10. Niederman MS, Soulountsi V (2011) De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? Clin Chest Med 32:517-534
11. Leggieri N, Rida A, François P, Schrenzel J (2010) Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis 23:311-319
12. Pletz MW, Wellinghausen N, Welte T (2011) Will polymerase chain reaction (PCR)-based diagnostics improve outcome in septic patients? A clinical view. Intensive Care Med 37:1069-1076